- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05780762
Impact of an Intervention Integrating the MPHS Nursing Model of Care on the Partnership in Health, With the Patient Followed in Primary Care by an Advanced Practice Nurse (APN) for One or More Stabilized Chronic Pathologies (IMPACT)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The IMPACT program proposes to integrate the MPHS model into primary care, within advanced practice nursing care, to strengthen the partnership of the patient with chronic disease. This model will allow the advanced practice nurse to co-construct with the patient partner a care trajectory that will be integrative, considering his aspirations and priorities to carry out his life project, while coping with his chronic pathology(ies). To do this, particular attention to the determinants of adaptation to chronic disease: self-management capacity, health literacy, quality of life and experience of care is pay.
The IMPACT program will use the theoretical framework of the MPHS model of care to structure the advanced practice nursing care management and will incorporate validated measurement tools to address the determinants of patient adaptation to chronic disease. The specific management of the IMPACT program will consist of 3 phases: (1) co-definition of the health situation, (2) co-planning of care and co-actions, and (3) co-assessment with the patient and the team caring for him/her.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Amandine BAUDOT, CRA
- Phone Number: +33 (0)477829450
- Email: Amandine.Baudot@chu-st-etienne.fr
Study Contact Backup
- Name: Franck CHAUVIN, PhD
- Phone Number: +33 (0)664816586
- Email: franck.chauvin@univ-st-etienne.fr
Study Locations
-
-
-
Saint-Étienne, France
- Recruiting
- Direction de la Prévention et de la Santé des Populations
-
Principal Investigator:
- Franck CHAUVIN, MD PhD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Followed by APN, within the framework of an organizational protocol established with a patient's referring physician, for the management of one or more chronic pathology(ies) from the following list: stroke; chronic arterial disease; heart disease, coronary artery disease; type 1 diabetes and type 2 diabetes; chronic respiratory failure; Parkinson's disease; epilepsy
- Affiliated or entitled to a social security plan
- Having received informed information about the study and having co-signed, with the investigator, a consent to participate in the study
Exclusion Criteria:
- Patient not referred by a physician for APN follow-up
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: IMPACT program - experimental group
patients followed for one or more stabilized chronic pathologies and benefiting from usual care with an Advanced Practice Nurse AND benefiting from the IMPACT program, which combines management at 3 levels: (1) co-definition of the health situation, (2) co-planning of care and co-actions, and (3) co-assessment with the patient and his or her care team, and incorporates evidence-based measurement tools.
|
care at 3 levels: (1) co-definition of the health situation, (2) co-planning of care and co-actions, and (3) co-assessment with the patient and with the team caring for him or her, and incorporating evidence-based measurement tools. |
Sham Comparator: Usal care : control group
patients followed for one or several stabilized chronic pathology(ies) and benefiting from a usual management with a Nurse in Advanced Practice.
|
usual management with a Nurse in Advanced Practice.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The patient/advanced practice nurse partnership
Time Frame: At month 9
|
The patient/advanced practice nurse partnership will be assessed by a measure via the PIH-Fv (Partners In Health scale French version) questionnaire at 9 months. The PIH-Fv (Partners In Health scale in French version) questionnaire was developed and validated in French by Hudon et al. The PIH-Fv scale is a self-assessment questionnaire that includes 12 items, which are answered using 9-point Likert-type scales. The total score goes from 0 to 96: 0 representing poor self-management and 96 better self-management. |
At month 9
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The patient/advanced practice nurse partnership across the continuum of care
Time Frame: baseline, 3 and 6 months
|
Measurement of the impact of the intervention on the partnership via the Partners In Health scale French version.This questionnaire is a self-assessment questionnaire that includes 12 items, which are answered using 9-point Likert-type scales.
The total score goes from 0 to 96: 0 representing poor self-management and 96 better self-management.
|
baseline, 3 and 6 months
|
Perception of health-related quality of life
Time Frame: At inclusion, 3, 6 and 9 months.
|
Measurement of the perception of health-related quality of life via the World Health Organisation Quality Of Life questionnaire.
This questionnaire questions 4 domains: physical health, psychological health, social sphere and environment.
The patient answers according to 3 groups of 5 modalities of the Likert scale.
The first group goes from " very weak " to " very good"; the second goes from " very unsatisfied " to "very satisfied" ; the third goes from "not at all" to " extremely"
|
At inclusion, 3, 6 and 9 months.
|
Health literacy level
Time Frame: at inclusion, 3, 6 and 9 months
|
Measurement of health literacy level via the European Health Literacy Survey (HLS-EU16) questionnaire validated in French version.
It consists of 16 items, for which the patient answers according 4 modalities "very easy" to "very difficult".
|
at inclusion, 3, 6 and 9 months
|
Impact of the quality of advanced practice nurse consultation from patient's perspective
Time Frame: At baseline, 3, 6 and 9 months
|
Measurement of the impact of the advanced practice nurse consultation on the patient's perceived ability to understand and cope with his or her health problems and illness via the PEI questionnaire vf (Patient Enablement Instrument French version) questionnaire.
It consists of 6 questions to which the patient responds in 3 ways "much more", "more", or "as before the visit or less"
|
At baseline, 3, 6 and 9 months
|
Adoption of IMPACT program by advanced practice nurse
Time Frame: 3 years
|
Adoption of IMPACT program by advanced practice nurse will be assessed by number of advanced practice nurses including patients and number of patients followed by each APN
|
3 years
|
Participation in IMPACT program
Time Frame: 3 years
|
Participation in IMPACT program will be assessed by number of patients who agreed to be followed with this model of care/number of patients who were offered follow-up
|
3 years
|
IMPACT program satisfaction for advanced practice nurse
Time Frame: 3 years
|
IMPACT program satisfaction will be assessed by semi-structured interview with advanced practice nurse
|
3 years
|
effectiveness of IMPACT program
Time Frame: 3 years
|
Effectiveness of IMPACT program will be assessed by proportion of patients completing the proposed follow-up package
|
3 years
|
Context of IMPACT program
Time Frame: 3 years
|
Context of IMPACT program will be assessed with semi-structured interviews with advanced practice nurse which will evaluate factors favoring and hindering the implementation, the adaptation, the achievement and sustainbility of the IMPACT program
|
3 years
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Franck CHAUVIN, PhD, CHUSE
- Principal Investigator: Elise VEROT, MD, CHUSE
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 21GI262
- ANSM (Other Identifier: 2023-A01346-39)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Disease
-
3-C Institute for Social DevelopmentUniversity of North Carolina, Chapel HillCompletedChronic Kidney Diseases | Chronic Kidney Disease Stage 5 | Chronic Kidney Disease stage4 | Pediatric Kidney Disease | Chronic Kidney Disease stage3 | Chronic Kidney Disease Stage V | Chronic Kidney Disease, Stage IV (Severe) | Chronic Kidney Disease Stage 2 | Chronic Kidney Disease, Stage IUnited States
-
Parker Research InstituteOak Foundation; Rehabilitation Center Rødovre Municipality (Genoptræning Rødovre... and other collaboratorsRecruitingChronic Disease | Chronic Conditions, Multiple | Chronic ConditionDenmark
-
Parker Research InstituteOak Foundation; Rehabilitation Center Rødovre Municipality (Genoptræning Rødovre... and other collaboratorsCompletedChronic Conditions, Multiple | Chronic ConditionDenmark
-
Universiti Putra MalaysiaRecruitingChronic Kidney Diseases | Chronic Kidney Disease Stage 5 | Chronic Kidney Disease stage4 | Chronic Kidney Disease stage3 | Chronic Kidney Disease Requiring Chronic DialysisMalaysia
-
University of LimerickRecruitingChronic Conditions, MultipleIreland
-
Radboud University Medical CenterRecruitingChronic Conditions, Multiple | Chronic ConditionNetherlands
-
University of Alabama at BirminghamRecruitingDisability Physical | Chronic Conditions, Multiple | Chronic ConditionUnited States
-
National Taiwan University HospitalCompletedChronic Kidney Disease stage4 | Chronic Kidney Disease stage3 | Chronic Kidney Disease Stage 2 | Chronic Kidney Disease Stage 1Taiwan
-
Centre Hospitalier le MansLe Mans UniversiteRecruitingFatigue | Chronic Kidney Disease Stage 5 | Chronic Kidney Disease stage4 | Chronic Kidney Disease Stage 3BFrance
-
Radboud University Medical CenterRecruiting
Clinical Trials on IMPACT Program
-
Aarhus University HospitalUniversity of AarhusRecruitingCognitive Impairment | Brain CancerDenmark
-
University Hospital, LilleSantelys Association; Groupement Interrégional de Recherche Clinique et d'InnovationRecruitingPancreatic Cancer | SarcopeniaFrance
-
Université du Québec à ChicoutimiMcGill University; Université de Sherbrooke; University of Alberta; University... and other collaboratorsRecruitingAutosomal Recessive Spastic Ataxia of Charlevoix-Saguenay | Spastic Paraplegia 7Canada
-
University of MalayaRecruitingSpasticity as Sequela of StrokeMalaysia
-
University of PennsylvaniaNot yet recruitingChronic Kidney Diseases | Trauma, Psychological | Racism, Systemic
-
University of Alabama at BirminghamCompleted
-
Ethiopian Public Health InstituteWageningen University; Micronutrient InitiativeCompletedGrowth Acceleration | Infant MorbidityEthiopia
-
University of Vic - Central University of CataloniaCompleted
-
Centre Hospitalier Universitaire de NiceNovartisCompleted
-
Vanderbilt UniversityNational Institute on Deafness and Other Communication Disorders (NIDCD)CompletedAutism Spectrum DisorderUnited States